
3D Systems heads into its third-quarter report with a turnaround story that looks better on paper than it does on the stock chart. Management spent the last call describing a recovery that had spread across all four of its priority markets, backed by surging printer sales, a record rocket-engine casting order and faster denture adoption. Yet the shares have fallen nearly 11% since that report while the S&P 500 edged higher. The November 4 release, due after the close, is the first real chance to show whether that disconnect reflects investor fatigue or a narrative that has gotten ahead of the numbers.
The Street is looking for revenue of $97.4 million, up 6.7% from a year ago, and a non-GAAP loss of $0.06 per share. That revenue estimate sits almost exactly at the midpoint of management's $96 million to $99 million guidance, which itself was set above where analysts stood at the time. In other words, consensus has fully absorbed the raised outlook, so simply landing in the range is not much of a win. The whisper number of a $0.01 loss is meaningfully better than consensus, suggesting some investors expect cost discipline and mix to deliver more on the bottom line than the official estimate implies. With management guiding to adjusted EBITDA of negative $1 million to $3 million, a near-breakeven per-share result would require either top-line upside or better gross margin than the company has recently managed.
The operating questions flow directly from last quarter's call. Printer sales jumped more than 45% in the second quarter, with the DMP350 metal and SLA825 polymer systems leading the way. Hardware is lumpy, so the key test is whether that pace holds and whether the large multi-quarter rocket-casting order begins showing up in revenue. Dentures are the other pillar: the NextDent 300 had reached roughly 100 of the top labs, EU approval was secured and production targets were raised twice this year. Investors should look for evidence that the noted supply constraint on electrical components did not cap shipments. Progress in data center and semiconductor work, which grew about 30%, and any early traction from the nuclear materials partnership with Savannah River National Laboratory would reinforce the idea of genuinely new demand.
The risks are just as concrete. Industrial revenue slipped 3.7% last quarter as jewelry, service bureaus and Chinese pricing pressure weighed, and a further decline would undercut the claim of a broad recovery. Gross margin has been stuck around 36% to 37%, held back by a heavier printer mix and helped last quarter by $2.6 million of tariff refunds that may not recur. With the $60 million cost program finished, savings are now in the base, so margin improvement has to come from mix and volume. Commentary on the CEO succession will also matter, since execution continuity is an open question for a company still short of sustained profitability, and the recent $53 million equity raise adds dilution to the per-share math.
Sentiment has swung from mildly bearish before the last report to moderately bullish now, even as the stock has lagged. Shares trade at $2.95, above the 200-day average of $2.78 but closer to the post-earnings low of $2.72 than the $3.90 high, a sign that the market wants proof rather than promises.
Ultimately, this report hinges on whether printer and denture strength can lift revenue toward the top of guidance while gross margin holds without tariff help. Do that while stabilizing industrial sales, and the turnaround case regains credibility through the leadership change. Fall short, and the recovery will look narrower and more fragile than management described.
This earnings preview was originally published on Earnings Whispers.
This article is for informational purposes only and is not investment advice. Earnings Whispers and its staff may hold positions in the securities mentioned. It is AI-assisted, based on proprietary Earnings Whispers data and company reports, and edited by Earnings Whispers staff.
| Oct-28 | |
| Oct-27 | |
| Oct-26 | |
| Oct-22 | |
| Oct-21 | |
| Sep-08 | |
| Aug-27 | |
| Aug-10 | |
| Aug-04 | |
| Aug-04 | |
| Aug-03 | |
| Aug-03 | |
| Jul-29 | |
| Jul-28 | |
| Jul-27 |
Join thousands of traders who make more informed decisions with our premium features. Real-time quotes, advanced visualizations, alerts, and much more.
Learn more about Finviz Elite